LMG Life Sciences Awards EMEA 2024: open for nominations

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

LMG Life Sciences Awards EMEA 2024: open for nominations

Copy of EMEA awards 2024-Shortlist Announced-1200x627.png

The EMEA region research cycle has commenced - do not miss this opportunity to nominate your work from 2023!

The EMEA region research cycle has commenced – do not miss this opportunity to nominate your work from 2023!

The LMG Life Sciences is excited to announced the launch of the 2024 research. We continue to recognise the top firms, lawyers, and legal work serving the Life Sciences industry from throughout the Europe, Middle East, & Africa region.

The deadline for nominations is 25 January 2024.

You can find detailed information about the awards by downloading the methodology, or reading the FAQs and the full list of categories on the LMG Life Sciences website.

Important Dates:

Nominations Open

Nominations Close

Shortlist Published

Gala Ceremony

8 December 2023

25 January 2024

March 2024

May 2024


All nominations to the awards must be entered through our dedicated nomination gateway. Nominations made in any other format or emailed to us will not be accepted.

For any questions about the awards or the research, please contact research editor, John Harrison.

For queries about business development and commercial opportunities, please contact George Reeves.

LMG Life Sciences Awards

The LMG Life Sciences awards look to recognise leading law firms and lawyers specialised in the life sciences industry throughout the Europe, Middle East, and Africa region. The awards ceremony will take place to celebrate outstanding legal work over the previous calendar year. The awards ceremony aims to honour firms and attorneys on the forefront of legal work in life sciences. The award’s distinctive structure highlights firms that specialise in practice areas within the life sciences industry by shortlisting firms and by listing our life sciences nominees in a way that shows overlap between certain legal areas.


Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IP Stars research.

more from across site and SHARED ros bottom lb

More from across our site

Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Max Scott will join the firm’s IP transactions group in California, becoming the latest Weil IP partner to secure their future
Yonatan Drori, attorney at Drori-Stav IP in Israel, explains why foreign counsel must treat Israel’s patent disclosure requirements as an ongoing obligation, rather than a one-off formality
Gift this article